Speaker Profile

___	__
	Biography Dr. Shea is an Assistant Professor in the Departments of Obstetrics & Gynecology and Psychiatry at McMaster University. She completed her fellowship in Menopause and Reproductive Mental Health and her residency in Obstetrics and Gynecology at the University of Toronto. She is a board member for the Canadian Menopause Society. She is a Menopause Society certified menopause practitioner and part of their education and examination committees. Dr. Shea has a unique expertise as she has completed additional training in reproductive mental health as well as PhD in Neuroscience & Behavioural Science. Disclosure 1. I have a relationship with a for-profit and/or a not-for-profit organization to disclose: - Direct financial payments including receipt of honoraria: Orgnanon, Lupin, Pfizer, Esaia - Membership on advisory boards or speakers’ bureaus: Eisai, Lupin, Pfizer - Funded grants or clinical trials: Pfizer 2. I do intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).

Biography
Dr. Shea is an Assistant Professor in the Departments of Obstetrics & Gynecology and Psychiatry at McMaster University. She completed her fellowship in Menopause and Reproductive Mental Health and her residency in Obstetrics and Gynecology at the University of Toronto. She is a board member for the Canadian Menopause Society. She is a Menopause Society certified menopause practitioner and part of their education and examination committees. Dr. Shea has a unique expertise as she has completed additional training in reproductive mental health as well as PhD in Neuroscience & Behavioural Science.
Disclosure
1. I have a relationship with a for-profit and/or a not-for-profit organization to disclose: - Direct financial payments including receipt of honoraria: Orgnanon, Lupin, Pfizer, Esaia - Membership on advisory boards or speakers’ bureaus: Eisai, Lupin, Pfizer - Funded grants or clinical trials: Pfizer 2. I do intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).